Free Trial
CVE:KNE

Kane Biotech (KNE) Stock Price, News & Analysis

Kane Biotech logo
C$0.05 +0.01 (+11.11%)
As of 07/10/2025 09:40 AM Eastern

About Kane Biotech Stock (CVE:KNE)

Key Stats

Today's Range
C$0.05
C$0.05
50-Day Range
C$0.05
C$0.08
52-Week Range
C$0.05
C$0.16
Volume
1,000 shs
Average Volume
70,013 shs
Market Capitalization
C$7.20 million
P/E Ratio
1.25
Dividend Yield
3.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter.

KNE Stock News Headlines

Kane Biotech Provides Further Corporate Update
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Directors buying at Kane Biotech (KNE)
See More Headlines

KNE Stock Analysis - Frequently Asked Questions

Kane Biotech's stock was trading at C$0.11 at the start of the year. Since then, KNE stock has decreased by 54.5% and is now trading at C$0.05.

Shares of KNE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kane Biotech investors own include Mason Resources (LLG), Datametrex AI (DM) and Allstar Health Brands (ALST).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:KNE
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$0.04
Trailing P/E Ratio
1.25
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$6.03 million
Net Margins
423.52%
Pretax Margin
N/A
Return on Equity
-94.49%
Return on Assets
-58.43%

Debt

Debt-to-Equity Ratio
-331.42
Current Ratio
0.80
Quick Ratio
0.39

Sales & Book Value

Annual Sales
C$1.42 million
Price / Sales
5.06
Cash Flow
C$0.01 per share
Price / Cash Flow
8.50
Book Value
C($0.01) per share
Price / Book
-9.71

Miscellaneous

Outstanding Shares
144,060,190
Free Float
N/A
Market Cap
C$7.20 million
Optionable
Not Optionable
Beta
0.52
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:KNE) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners